-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
February 05, 2025 - cancersb Solid tumor cancers, including breast, prostate, testicular,
cervical, and colon cancer. … D. … / or exp "Neoplasms, Germ Cell and Embryonal"/ or
(hematologic cancer* or hematologic neoplasms or hematologic … Neoplasms/ or liver neoplasms/ or Prostatic Neoplasms/ or Testicular Neoplasms/ or
Testicular Neoplasms … / or Uterine Cervical Neoplasms/ or ((cancer* or carcinoma?
-
effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
April 01, 2016 - Sorensen G, McLellan D, Dennerlein JT, et al. … Cancer Causes
Control. 2009 Aug;20(6):887-94. PMID: 19301135.
21. … Cancer Causes Control. 2007 Feb;18(1):51-9.
PMID: 17186421.
28. … Schulz KF, Altman DG, Moher D, et al. … Atkins D, Chang SM, Gartlehner G, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
May 01, 2013 - D. … screening, where the metric was
colonoscopies per cancer death prevented, or in cervical cancer screening … , where the metric was
colposcopies per cancer death prevented. … In these situations, a grade of insufficient will be assigned. … Moher D, Fortin P, Jadad AR, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - C-1
Appendix D. … D-1
Appendix E. … D-1
Appendix D. Literature Flow Diagram
Figure D-1. … Takakuwa KM, Sulak D. … Medical
cannabis or cannabinoids for chronic non-
cancer and cancer related pain: a systematic
review
-
effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
February 01, 2018 - • There is no evidence that supports the use of fidaxomicin in life-threatening CDI (D-III). … Magee G, Strauss ME, Thomas SM, Brown
H, Baumer D, Broderick KC. … The University of Texas MD Anderson
Cancer Center. … Houston (TX): The University of Texas
MD Anderson Cancer Center; 2017. 10 p. … rating: GRADE system
5.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
August 01, 2017 - Qaseem A, Kansagara D, Forciea MA, et al. Ann Intern Med. 2016 Jul
19;165(2):125-33. … † The overall evidence grade was assessed based on the ratings for the following domains: study limitations … on the methodology used to assess strength of evidence, please refer to: Owens DK, Lohr KN, Atkins D, … Food and Drug Administration
(FDA) for insomnia.
d Other benzodiazepines include drugs approved by … �» Zolpidem: head injury or fracture requiring
hospitalization, hip fracture, cancer
�» Ramelteon
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
April 01, 2012 - Table D. … Table D. … total adverse events,100 incidence of headache,100
gastrointestinal discomfort,100 incidence of cancer … Garg RK, Nag D, Agrawal A. … Aruna D, Naidu MU.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
May 01, 2019 - evidence on the outcome was too weak, sparse,
or inconsistent to permit any conclusion to be
drawn, a grade … • Women who undergo IVF demonstrated
an increased risk of ovarian neoplasms and
colorectal malignancies … ovarian tumors, and colorectal cancer
No difference: IVF however was not
associated with an increased … Sun X, Zhang D, Zhang W. … Effects
of fertility drugs on cancers other than breast and
gynecologic malignancies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
December 11, 2018 - D. … The
strength of evidence will be assigned an overall grade of high, moderate, low, or
insufficient … Boudreau D, Von Korff M, Rutter CM, et al. … Trends in long-term opioid therapy for
chronic non-cancer pain. … Dowell D, Haegerich TM, Chou R.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
April 01, 2012 - Oral DMARDs
Anti-tumor necrosis factor
drugs vs. … Those with high-
risk comorbidities (cardiovascular events, diabetes,
malignancies, renal impairment … evidence does
not suggest an increased risk of severe adverse events,
including cardiovascular or cancer … Most studies found no risk of cardiovascular events and
malignancy with biologic DMARDs, except for … Owens DK, Lohr KN, Atkins D, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
March 09, 2010 - Specifically, we will examine mortality, malignancy, serious infection,
hepatitis, bone marrow suppression … D. … In these situations, a grade of “insufficient” will be assigned. … Myers E, McCrory D, Mills A, et al. Effectiveness of Assisted Reproductive Technology. … Outcomes, Timing, Settings
RCTs Randomized Controlled Trials
TEP Technical Expert Panel
TNF Tumor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
March 01, 2012 - Quality (AHRQ) for its
Effective Healthcare Program.20 This method is based
on one developed by the Grade … Working Group,21 and
classifies the grade of evidence according to the following
criteria:
High … The evidence grade is based on four primary domains
(required) and four optional domains. … d. … D. Birnbaum, H. G. Oster, E. F. Lufkin, E.
Mallet, D.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-237-evidence-summary-palliative-care-ambulatory.pdf
February 01, 2021 - ambulatory care for adults with serious life-
threatening chronic illness and conditions other than cancer … Methods
We completed a mixed-methods review focusing on serious chronic illnesses other
than cancer … Waldfogel JM, Sloan DH, Cotter V, Hannum S, Heughan J, Chyr L, DeGroot L, Wilson
R, Zhang A, Mahabare D,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
February 01, 2014 - We used four domains to yield a final evidence
grade: risk of bias, consistency, directness and precision … The final strength-of-evidence (SOE) grades were:
(1) “high” grade (indicating high confidence that … outcomes—adherence, serious adverse events (as reported by investigators),
withdrawal due to adverse events, cancer … final.cfm.
6
very unlikely to change our confidence in the estimate
of the effect); (2) “moderate” grade … confidence in the estimate of the effect and is likely
to change the estimate); and (4) “insufficient” grade
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
September 01, 2014 - included in the ECRI report stated that
open surgical biopsy may miss one to two percent of breast
cancers … Table D. … BMC Cancer. 2012;12:41. PMID: 22277164.
5. Bernardi D, Borsato G, Pellegrini M, et al. … Moher D, Liberati A, Tetzlaff J, et al. … Wells G, Shea B, O’Connell D, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/malnutrition-hospitalized-adults-protocol.pdf
October 19, 2020 - can result from chronic starvation (e.g., anorexia nervosa); acute or chronic illness (e.g., certain
cancers … Medicaid beneficiaries)
• Patients with malignancy
• Patients with gastrointestinal disease and subsequent … Studies of patients in specialty hospitals
(e.g., psychiatric, ophthalmologic, orthopedic, cancer, … Owens D, Lohr K, Atkins D, et al. … The fate of abstracts submitted to a cancer
meeting: factors which influence presentation
and subsequent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
May 02, 2011 - free survival, remission, and
light chain escape
Diagnostic
accuracy for
a) MGUS
b) MM
c) NSMM
d) … will be retrieved from existing guidelines and narrative and
systematic reviews and a search of other cancer-specific … D. … Grading the Evidence for Each Key Question
We will follow the Methods Guide11 to grade the strength … Atkins D, Eccles M, Flottorp S, et al, for the GRADE Working Group.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - or racial groups, and sex);
Patients with medical comorbidities (e.g., ischemic heart disease, cancer … D. … racial groups, and
sex);
Patients with medical comorbidities (e.g., ischemic heart disease,
cancer … of evidence and the strength of recommendations I: Critical appraisal of existing
approaches: The GRADE … Owens DK, Lohr KN, Atkins D, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
January 01, 2006 - deaths due to NSAID-induced gastrointestinal
complications, a higher death rate than that for cervical
cancer … include long-term studies of these drugs for treating
osteoarthritis or rheumatoid arthritis and for cancer … • Glucosamine and chondroitin
• In one large, good-quality trial the combination
of pharmaceutical-grade … • Most trials showing therapeutic benefits from
glucosamine were conducted using
pharmaceutical-grade … NSAIDs are needed, as these
are likely to remain available even if the FDA
approves pharmaceutical-grade
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
March 31, 2010 - hypertension; high cholesterol; stroke;
heart disease; nonalcoholic fatty liver
disease; certain cancers … Within this hierarchy,
each study contributed only one weight-related measure
to the grade. … We did not grade
adverse events or clinical outcomes. … Owens DK, Lohr KN, Atkins D, et al. … Atkins D, Chang SM, Gartlehner G, et al.